Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Exclusives

More »

For full access to this article login to GEN Select now.

July 22, 2014

"Know Your Enemy" Takes Cell Therapy to Next Level

Whether they involve screening for active cells or introducing new receptors, therapies that boost the immune system’s response to cancer are becoming more specific and widely available.

"Know Your Enemy" Takes Cell Therapy to Next Level

Kite Pharma Chimeric Antigen Receptor (CAR) Technology.

The idea has intrigued researchers for at least a couple of decades: Open a new front against cancer by enhancing the tumor-fighting abilities of T cells Only recently, however, has the idea seemed anywhere near realization T-cell ranks, so often full of live-and-let-live types, can now be populated with tumor-targeting ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.

Related content